[ad_1]
Basilea Pharmaceutica AG GAAP EPS of CHF 1.02, revenue of CHF 147.8M; initiates FY22 guidance
[ad_2]
Source link
(This article is generated through the syndicated feed sources, Financetin doesn’t own any part of this article)
[ad_1]
Basilea Pharmaceutica AG GAAP EPS of CHF 1.02, revenue of CHF 147.8M; initiates FY22 guidance
[ad_2]
Source link
(This article is generated through the syndicated feed sources, Financetin doesn’t own any part of this article)
